Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Sterile Injectable Manufacturing: SOP for Visual Inspection of Packaging Materials – V 2.0

Posted on By

Sterile Injectable Manufacturing: SOP for Visual Inspection of Packaging Materials – V 2.0

Standard Operating Procedure for Visual Inspection of Packaging Materials


Department Sterile Injectable Manufacturing
SOP No. SOP/SIM/091/2025
Supersedes SOP/SIM/091/2022
Page No. Page 1 of 12
Issue Date 18/06/2025
Effective Date 20/06/2025
Review Date 18/06/2026

1. Purpose

This SOP defines the systematic procedure for visual inspection of packaging materials (e.g., vials, rubber stoppers, flip-off seals, labels, cartons) used in sterile injectable manufacturing to ensure they meet the predefined specifications and are free from defects.

2. Scope

This procedure applies

to the visual inspection of all primary and secondary packaging materials received and stored for use in the sterile injectable manufacturing unit.

3. Responsibilities

  • Warehouse Personnel: To conduct initial visual checks upon material receipt.
  • IPQA Officer: To verify and document findings of visual inspection.
  • QC Inspector: To evaluate suspect lots or any observed nonconformance.
See also  Manufacturing: SOP for Temperature and Humidity Monitoring during Production - V 2.0

4. Accountability

The Head of Quality Assurance is accountable for compliance with this SOP and implementation of corrective actions for any identified deviations.

5. Procedure

5.1 Preparation

  1. Ensure cleanliness of the inspection area and availability of adequate lighting.
  2. Retrieve packaging materials from quarantine/storage area as per the dispatch note or requisition.
  3. Use the Packaging Material Visual Inspection Checklist (Annexure-1) during the process.

5.2 Inspection Criteria

  1. Vials: Check for cracks, scratches, embedded particles, discoloration, irregular shapes, or foreign matter.
  2. Rubber Stoppers: Inspect for surface defects, color inconsistencies, embedded particles, or deformities.
  3. Flip-off Seals: Ensure print legibility, proper color coding, and freedom from dents or missing parts.
  4. Labels & Leaflets: Check for misprints, blurring, missing information, wrong artwork, and batch placeholders.
  5. Cartons & Shippers: Inspect for physical damage, wetness, incorrect printing, and layout mismatches.

5.3 Acceptance and Rejection

  1. Segregate the inspected lot into “Accepted” and “Rejected” areas clearly marked within the inspection zone.
  2. Fill the Packaging Material Inspection Record (Annexure-2) for each inspected lot.
  3. Rejected material shall be labeled as “Rejected – Hold for Disposition” and sent to QC for further evaluation.
  4. Accepted lots shall be labeled “Approved” and transferred to approved storage locations.
See also  Sterile Injectable Manufacturing: SOP for Troubleshooting Autoclave Issues in Sterilization - V 2.0

5.4 Handling of Non-Conformance

  1. Initiate a Non-Conformance Report (NCR) (Annexure-3) for any rejected batch.
  2. QC shall evaluate the defect type and decide on reinspection, return, or destruction.
  3. Update the Defect Trending Log (Annexure-4) for repeated issues with supplier materials.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • IPQA: In-Process Quality Assurance
  • QC: Quality Control
  • NCR: Non-Conformance Report

7. Documents

  1. Packaging Material Visual Inspection Checklist – Annexure-1
  2. Packaging Material Inspection Record – Annexure-2
  3. Non-Conformance Report – Annexure-3
  4. Defect Trending Log – Annexure-4

8. References

  • ICH Q10 – Pharmaceutical Quality System
  • WHO GMP Guidelines for Pharmaceuticals
  • ISPE Baseline Guide Vol. 6 – Packaging

9. SOP Version

Version: 2.0

See also  Sterile Injectable Manufacturing: SOP for Handling Out-of-Trend (OOT) Results in Manufacturing - V 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Manufacturing Executive QA Executive Head QA
Department Production Quality Assurance Quality Assurance

11. Annexures

Annexure-1: Packaging Material Visual Inspection Checklist

Material Type Checked For Acceptable (Y/N) Remarks
Rubber Stopper Surface Cleanliness Y OK

Annexure-2: Packaging Material Inspection Record

Material Supplier Batch No. Status Inspected By
Glass Vials Indian Pharma Glass G1234 Approved Sunita Reddy

Annexure-3: Non-Conformance Report (NCR)

Material Defect Observed Disposition QC Decision
Flip-off Seal Print Missing Return to Supplier Approved

Annexure-4: Defect Trending Log

Supplier Material Defect Type Occurrences
PharmaSeal Ltd. Seals Print Smudging 3

Revision History

Revision Date Revision No. Details Reason Approved By
05/03/2022 1.0 Initial version New SOP QA Head
18/06/2025 2.0 Updated visual criteria, added trending log Annual review QA Head
Injectables V 2.0 Tags:Aseptic processing SOP, Aseptic technique in sterile manufacturing, Cleanroom SOP for injectables, SOP for ampoule sealing, SOP for autoclave sterilization, SOP for container closure integrity testing, SOP for environmental monitoring in aseptic area, SOP for gowning in cleanroom, SOP for in-process checks in sterile manufacturing, SOP for injectable formulation, SOP for lyophilizer operation, SOP for sterile filtration, SOP for sterilization validation, SOP for vial filling, SOP for visual inspection of injectables, Sterile area cleaning SOP, Sterile filling line SOP, Sterile injectable quality control SOP, Sterile injection SOP, Sterile manufacturing procedure

Post navigation

Previous Post: Biosimilars: SOP for Material Traceability in Upstream – V 2.0
Next Post: SOP for Conducting Regulatory Gap Assessments

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version